Secrecy surrounds AMC aid deal for drug industry

The medical aid group MSF says a USD 1.5 billion aid deal to develop new vaccines for poor countries is much too lucrative for the drug industry. MSF has estimated an earlier version of the scheme to be overpriced by USD 600 million, but has been denied basic facts about the latest proposal. Donors are to settle the deal May 20.